30 /100
MEDIUM RISK
Score updated Jul 13, 2026

BCAT — BlackRock Capital Allocation Term Trust Dilution Risk Tracker

Track BCAT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BCAT — Get alerts when the score changes →

As of July 13, 2026, BlackRock Capital Allocation Term Trust (BCAT) has a DilutionWatch DilutionScore of 30/100, rated MEDIUM dilution risk. BlackRock Capital Allocation Term Trust has a market capitalization of $1.67B, 104.78M shares outstanding, 102 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
39
💰 Cash Runway
25
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BCAT.
🔔 Track BCAT — Get forecast alerts →

💹 Market Data

Market Cap$1.67B
Shares Outstanding104.78M
FloatN/A
CashN/A
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 26.9% shares (2026Q1 vs prior)
102 institutional holders · 28.70M shares
#1 MORGAN STANLEY 13.09M shares
#2 WELLS FARGO & COMPANY/MN 2.52M shares
#3 COHEN & STEERS, INC. 1.65M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.16M
Days to Cover1.9
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for BCAT Shareholders

BlackRock Capital Allocation Term Trust (BCAT) has a DilutionScore of 30/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for BCAT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BCAT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BCAT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BCAT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BCAT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BCAT
📊 BCAT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BCAT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.